Mc Guire Investment Group, LLC Recursion Pharmaceuticals, Inc. Transaction History
Mc Guire Investment Group, LLC
- $654 Million
- Q4 2024
A detailed history of Mc Guire Investment Group, LLC transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Mc Guire Investment Group, LLC holds 23,500 shares of RXRX stock, worth $152,045. This represents 0.02% of its overall portfolio holdings.
Number of Shares
23,500Holding current value
$152,045% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding RXRX
# of Institutions
341Shares Held
284MCall Options Held
2.83MPut Options Held
3.64M-
Vanguard Group Inc Valley Forge, PA34MShares$220 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl32.3MShares$209 Million1.91% of portfolio
-
Baillie Gifford & CO24.9MShares$161 Million0.13% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$112 Million0.0% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M014.7MShares$94.9 Million0.44% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.17B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...